Einstek Pharma Private Limited
About Einstek Pharma Private Limited
Data last updated:
Einstek Pharma Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 22 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2016PTC085446. Its GSTIN is 29AAECE1691A1ZV (Karnataka).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Pachaiyappan Shanmugam and Rajambal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #R – 32 First Floor Kssidc Industrial Estate 2nd Stage Jigani Link Road Bommasandra, Bengaluru, Karnataka, India – 560099.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.18 Lakh, a decline of 66% compared to the previous year. For the same year it recorded a net loss of ₹1.5 Lakh (net margin -128%) and EBITDA of -₹69,311 (EBITDA margin -59%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Einstek Pharma Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address#R – 32 First Floor Kssidc Industrial Estate 2nd Stage Jigani Link Road Bommasandra, Bengaluru, Karnataka, India – 560099
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Einstek Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Einstek Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Einstek Pharma Private Limited, buy the company report.
Financials of Einstek Pharma Private Limited
FY 2025 filings availableEinstek Pharma Private Limited reported revenue of ₹1.18 Lakh (down 66% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 66% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹69,311 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -59% | ||||
| Net Profit Margin | -128% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Einstek Pharma Private Limited, buy the company report.
Board of directors of Einstek Pharma Private Limited
Einstek Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pachaiyappan Shanmugam | Director | 22 Jan 2016 | 10 Years 9 Months | Current |
| Rajambal | Director | 02 May 2018 | 8 Years 5 Months | Current |
Shareholding
The shareholding of Einstek Pharma Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Einstek Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Einstek Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Einstek Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Einstek Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECE1691A1ZV | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Einstek Pharma Private Limited, buy the company report.
Recent activity
Einstek Pharma Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Chandra Sekhar Gudla ceased to be Director on 06 May 2018.
Frequently asked questions
Einstek Pharma is an active private limited company based in Bengaluru, Karnataka, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 22 January 2016 (10+ years old) and is registered under CIN U24230KA2016PTC085446.
Einstek Pharma has 2 current directors:
- Pachaiyappan Shanmugam - Director
- Rajambal - Director
The latest financial statements of Einstek Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Einstek Pharma is 29AAECE1691A1ZV, registered in Karnataka.
The CIN (Corporate Identification Number) of Einstek Pharma is U24230KA2016PTC085446. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Einstek Pharma was incorporated on 22 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Chandra Sekhar Gudla ceased to be Director on 06 May 2018. Rajambal was appointed as Director on 02 May 2018. Pachaiyappan Shanmugam was appointed as Director on 22 Jan 2016.
The registered office of Einstek Pharma is at #R – 32 First Floor Kssidc Industrial Estate 2nd Stage Jigani Link Road Bommasandra, Bengaluru, Karnataka, India – 560099.
Einstek Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.
The compliance status of Einstek Pharma is compliant as of 23 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
